TBIO Insider Trading - Telesis Bio, Inc.

已發行股份	1,801,848 shares
內部人士股份	5,468,325 shares
所有內部人士	40

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

0 ( )

2850 out of 10948

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

0.000% ( )

2826 out of 10786

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Telesis Bio, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
Atlas Venture Associates VIII, Inc. 10% Owner - [10%]	3,922,010	217,889
Atlas Venture Associates VIII, L.P. 10% Owner - [10%]	3,922,010	217,889
Atlas Venture Fund VIII, L.P. 10% Owner - [10%]	3,922,010	217,889
Baupost Group Llc/ma 10% Owner - [10%]	0	0
Ann Barbier	150,000
Baupost Group GP, L.L.C. 10% Owner - [10%]	0	0
Daniella Beckman	0
Burgess Paul D. Chief Operating Officer, CLO - [O]	0	0
Paula Cloghessy See Remarks - [O]	102,480	5,693
George Demetri	0
Jean Francois Formela Director - [D]	0	0
Brian Fenton Chief Business Officer - [O]	250,990	13,944
Plc Glaxosmithkline 10% Owner - [10%]	3,697,912	205,440

內部人士	持股數量	分拆調整
Gallagher Brian M. Jr. Director - [D]	3,697,912	205,440
Michael Heartlein See Remarks - [O]	36,000	2,000
Owen Hughes Director - [D]	0	0
Seth A Klarman 10% Owner - [10%]	0	0
Daniel Lynch Director - [D]	643,650	35,758
Lim Richard J. 10% Owner - [10%]	1,458,424	81,024
MRL Ventures Fund LLC 10% Owner - [10%]	1,873,503	104,084
Meyer Robert J.	0
Claudio Nessi 10% Owner - [10%]	1,458,424	81,024
Omega Fund IV G.P. Manager, Ltd. 10% Owner - [10%]	1,458,424	81,024
Omega Fund IV GP, L.P. 10% Owner - [10%]	1,458,424	81,024
Omega Fund IV, L.P. 10% Owner - [10%]	1,458,424	81,024
Omega Fund V GP Manager, Ltd. 10% Owner - [10%]	1,458,424	81,024

內部人士	持股數量	分拆調整
Omega Fund V GP, L.P. 10% Owner - [10%]	1,458,424	81,024
Omega Fund V, L.P. 10% Owner - [10%]	1,458,424	81,024
Anne-Mari Paster 10% Owner - [10%]	1,458,424	81,024
Robert M Plenge	0
Ronald C JR Renaud Chief Executive Officer, Director - [D] [O]	0	0
Sanofi 10% Owner - [10%]	75,668,031	4,203,780
Schroer John R.	150,000
Shire Human Genetic Therapies, Inc. 10% Owner - [10%]	0	0
plc Shire 10% Owner - [10%]	7,078,945	393,275
Brendan Smith	0
Otello Stampacchia 10% Owner - [10%]	1,458,424	81,024
Everett Rand Sutherland	0
Pharmaceutical Co Ltd Takeda 10% Owner - [10%]	0	0
Richard Wooster	150,000

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 TBIO / Telesis Bio, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2021-09-14	Sanofi	51,467,612	38.0000	2,859,312	684.0000	1,955,769,256	2	239.04	-1,272,279,555	-65.05
2021-09-14	Sanofi	20,515,985	38.0000	1,139,777	684.0000	779,607,430
2020-06-26	BAUPOST GROUP LLC/MA	500,000	22.0000	27,778	396.0000	11,000,000
2018-07-02	GLAXOSMITHKLINE PLC	269,230	13.0000	14,957	234.0000	3,499,990
2018-07-02	MRL Ventures Fund LLC	25,000	13.0000	1,389	234.0000	325,000

經調整價格已按拆股調整。經調整股數已按拆股調整。

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 TBIO / Telesis Bio, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士進行過任何未預先計劃的公開市場交易。

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2021-09-16	2021-09-14	4/A	BAUPOST GROUP LLC/MA See footnote 1 and 2	TBIO	Common Stock	J - Other	I		38.0000	-18,044,239	-685,681		0
2021-09-14	2021-09-14	4	Sutherland Everett Rand	TBIO	Stock Option (right to buy)	S - Sale	D	16.37		-300,000		0
2021-09-14	2021-09-14	4	Smith Brendan	TBIO	Stcok Option (right to buy)	S - Sale	D	19.23		-201,800		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	8.34		-89,996		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7.39		-1,071,009		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stcok Option (right to buy)	S - Sale	D	23.82		-325,000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7.66		-525,000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	S - Sale	D	7.95		-500,000		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Common Stock	S - Sale	I		38.0000	-40,909	-1,555		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock	S - Sale	I		38.0000	-409,913	-15,577		0
2021-09-14	2021-09-14	4	Renaud Ronald C JR	TBIO	Common Stock	S - Sale	D		38.0000	-503,231	-19,123		0
2021-09-14	2021-04-07	4/A	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7.39		-9,026		1,071,009
2021-09-14	2021-04-07	4/A	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7.3900	9,026	67		503,231
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	23.82		-90,000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7.95		-150,000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7.66		-150,000		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	8.34		-69,953		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	S - Sale	D	7.39		-219,652		0
2021-09-14	2021-09-14	4	Burgess Paul D.	TBIO	Common Stock	S - Sale	D		38.0000	-71,833	-2,730		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	10.20		-18,900		0
2021-09-14	2021-09-14	4	Plenge Robert M	TBIO	Stock Option (right to buy)	S - Sale	D	12.36		-37,800		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	10.20		-18,900		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	S - Sale	D	7.49		-37,800		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (righ to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	10.20		-18,900		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Stock Option (right to buy)	S - Sale	D	7.39		-38,135		0
2021-09-14	2021-09-14	4	Hughes Owen	TBIO	Common Stock	S - Sale	D		38.0000	-29,860	-1,135		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	10.15		-37,800		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	8.34		-37,800		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	S - Sale	D	10.20		-18,900		0
2021-09-14	2021-09-14	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		38.0000	-2,055,063	-78,092		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Demetri George	TBIO	Stock Option (right to buy)	S - Sale	D	10.15		-37,800		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	20.43		-20,000		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	15.33		-18,900		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	10.20		-18,900		0
2021-09-14	2021-09-14	4	Beckman Daniella	TBIO	Stock Option (right to buy)	S - Sale	D	7.39		-67,995		0
2021-09-14	2021-09-14	4	Sanofi	TBIO	Common Stock, par value $0.001 per share	P - Purchase	D		38.0000	20,515,985	779,607		75,668,031
2021-09-14	2021-09-14	4	Sanofi	TBIO	Common Stock, par value $0.001 per share	P - Purchase	D		38.0000	51,467,612	1,955,769		55,152,046
2021-08-12		3	Sanofi	TBIO	Common Stock		D						3,684,434
2021-06-17	2021-06-16	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock (right to buy)	A - Award	D	20.43		20,000		20,000
2021-06-16	2021-06-16	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	20.43		20,000		20,000
2021-06-16	2021-06-16	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	20.43		20,000		20,000
2021-06-16	2021-06-16	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	20.43		20,000		20,000
2021-06-16	2021-06-16	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	20.43		20,000		20,000
2021-06-16	2021-06-16	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	20.43		20,000		20,000
2021-04-20	2021-04-19	4	Smith Brendan	TBIO	Stock Option (Right to Buy)	A - Award	D	19.23		201,800		201,800
2021-04-09	2021-04-07	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7.39		-9,026		1,071,009
2021-04-09	2021-04-07	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7.3900	9,026	67		503,321
2021-03-23	2021-03-22	4	Sutherland Everett Rand	TBIO	Stock Option (right to buy)	A - Award	D	16.37		300,000		300,000
2021-03-09	2021-03-09	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	23.82		325,000		325,000
2021-03-09	2021-03-09	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	23.82		70,000		70,000
2021-03-09	2021-03-09	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	23.82		70,000		70,000
2021-03-09	2021-03-09	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	23.82		90,000		90,000
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	8.34		-1		89,996
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7.39		-5,638		1,080,035
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		8.3400	1	0		494,205
2021-01-14	2021-01-14	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7.3900	5,638	42		494,204
2020-12-23	2020-12-22	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25.8825	-2,700	-70		43,940
2020-12-23	2020-12-22	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25.0421	-79,865	-2,000		46,640
2020-12-23	2020-12-21	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		25.5046	-56,536	-1,442		126,505
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	8.34		-3		89,997
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	M - Exercise	D	7.39		-53,004		1,085,673
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		8.3400	3	0		488,566
2020-11-18	2020-11-16	4	Renaud Ronald C JR	TBIO	Common Stock	M - Exercise	D		7.3900	53,004	392		488,563
2020-08-27	2020-08-27	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		14.3822	-10,097	-145		3,833,122
2020-08-27	2020-08-26	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		14.7979	-44,381	-657		3,843,219
2020-08-27	2020-08-25	4	FORMELA JEAN FRANCOIS	TBIO	Common Stock	S - Sale	I		15.0003	-34,410	-516		3,887,600
2020-06-30	2020-06-30	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20.6800	-6,824,992	-141,141		0
2020-06-30	2020-06-26	4	BAUPOST GROUP LLC/MA See footnote 1 and 2.	TBIO	Common Stock	P - Purchase	I		22.0000	500,000	11,000		18,044,239
2020-06-17	2020-06-16	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-17	2020-06-16	4	LYNCH DANIEL	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-17	2020-06-16	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-16	2020-06-16	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-16	2020-06-16	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-16	2020-06-16	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-16	2020-06-16	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	15.33		18,900		18,900
2020-06-05	2020-06-03	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19.7500	-40,086	-792		6,824,992
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14,157,890
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14,157,890
2020-06-03		3	TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses	TBIO	Common Stock A		I						14,157,890
2020-06-03	2020-06-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20.0200	-5,006	-100		6,865,078
2020-06-03	2020-06-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19.7500	-100,389	-1,983		6,870,084
2020-06-03	2020-06-01	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		20.5300	-1,400	-29		6,970,473
2020-06-03	2020-06-01	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	S - Sale	D		19.8500	-107,072	-2,125		6,971,873
2020-03-05	2020-03-03	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	7.66		150,000		150,000
2020-03-05	2020-03-03	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	7.66		525,000		525,000
2020-03-05	2020-03-03	4	Schroer John R.	TBIO	Stock Option (right to buy)	A - Award	D	7.66		150,000		150,000
2020-03-05	2020-03-03	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	7.66		150,000		150,000
2020-03-05	2020-03-03	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	7.66		150,000		150,000
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35,088,478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35,088,478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35,088,478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35,088,478
2019-09-20		3	KLARMAN SETH A See footnote 1,2	TBIO	Common Stock		I						35,088,478
2019-07-15	2019-07-12	4	Demetri George	TBIO	Stock Option (right to buy)	A - Award	D	10.15		37,800		37,800
2019-06-19	2019-06-18	4	FORMELA JEAN FRANCOIS	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-06-19	2019-06-18	4	Hughes Owen	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-06-19	2019-06-18	4	LYNCH DANIEL	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-06-19	2019-06-18	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-06-19	2019-06-18	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-06-19	2019-06-18	4	Beckman Daniella	TBIO	Stock Option (right to buy)	A - Award	D	10.20		18,900		18,900
2019-04-26	2019-04-24	4	Wooster Richard	TBIO	Stock Option (right to buy)	A - Award	D	9.40		360,000		360,000
2019-04-11	2019-04-10	4	Plenge Robert M	TBIO	Stock Option (right to buy)	A - Award	D	12.36		37,800		37,800
2019-03-12	2019-03-08	4	Schroer John R.	TBIO	Stock Option (right to buy)	A - Award	D	7.95		125,000		125,000
2019-03-12	2019-03-08	4	Barbier Ann	TBIO	Stock Option (right to buy)	A - Award	D	7.95		125,000		125,000
2019-03-12	2019-03-08	4	Burgess Paul D.	TBIO	Stock Option (right to buy)	A - Award	D	7.95		150,000		150,000
2019-03-12	2019-03-08	4	Cloghessy Paula	TBIO	Stock Option (right ot buy)	A - Award	D	7.95		60,000		60,000
2019-03-12	2019-03-08	4	Fenton Brian	TBIO	Stock Option (irght to buy)	A - Award	D	7.95		90,000		90,000
2019-03-12	2019-03-08	4	Heartlein Michael	TBIO	Stock Option (right to buy)	A - Award	D	7.95		150,000		150,000
2019-03-12	2019-03-08	4	Renaud Ronald C JR	TBIO	Stock Option (right to buy)	A - Award	D	7.95		500,000		500,000
2019-01-03	2019-01-02	4	Meyer Robert J.	TBIO	Stock Option (right to buy)	A - Award	D	7.49		37,800		37,800
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series C Preferred Stock	C - Conversion	I			-2,525,253		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series B Preferred Stock	C - Conversion	I			-7,222,797		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Series A Preferred Stock	C - Conversion	I			-9,300,000		0
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	P - Purchase	I		13.0000	269,230	3,500		3,697,912
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			454,550			3,428,682
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			1,300,116			2,974,132
2018-07-05	2018-07-02	4	Gallagher Brian M. Jr.	TBIO	Common Stock	C - Conversion	I			1,674,016			1,674,016
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Series C Preferred Stock	C - Conversion	I			-227,272		0
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Series C Preferred Stock	C - Conversion	I			-227,272		0
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock	C - Conversion	I			40,909			40,909
2018-07-03	2018-07-02	4	Renaud Ronald C JR By Ronald C. Renaud, Jr. Trust - 2007	TBIO	Common Stock	C - Conversion	I			40,909			40,909
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-2,525,253		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-5,838,230		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-12,925,244		0
2018-07-03	2018-07-02	4	Atlas Venture Fund VIII, L.P.	TBIO	Common Stock	C - Conversion	D			3,832,010			3,922,010
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-302,173		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series C Preferred Stock	C - Conversion	I			-302,173		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-2,000,103		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series B Preferred Stock	C - Conversion	I			-2,000,103		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-5,800,000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Series A Preferred Stock	C - Conversion	I			-5,800,000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series C Preferred Stock	C - Conversion	I			-1,263,484		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series C Preferred Stock	C - Conversion	D			-1,263,484		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series B Preferred Stock	C - Conversion	I			-1,676,348		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series B Preferred Stock	C - Conversion	D			-1,676,348		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Series A Preferred Stock	C - Conversion	D			-2,500,000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Series A Preferred Stock	C - Conversion	I			-2,500,000		0
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega V	TBIO	Common Stock	C - Conversion	I			1,458,424			1,458,424
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Common Stock	C - Conversion	D			1,458,424			1,458,424
2018-07-03	2018-07-02	4	Omega Fund IV, L.P.	TBIO	Common Stock	C - Conversion	D			979,179			979,179
2018-07-03	2018-07-02	4	Omega Fund IV, L.P. By Omega IV	TBIO	Common Stock	C - Conversion	I			979,179			979,179
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Series C Preferred Stock	C - Conversion	D			-1,010,101		0
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Series B Preferred Stock	C - Conversion	D			-9,259,259		0
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Common Stock	P - Purchase	D		13.0000	25,000	325		1,873,503
2018-07-03	2018-07-02	4	MRL Ventures Fund LLC	TBIO	Common Stock	C - Conversion	D			1,848,503			1,848,503
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series C Preferred Stock	C - Conversion	I			-2,525,253		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series B Preferred Stock	C - Conversion	I			-5,838,230		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Series A Preferred Stock	C - Conversion	I			-12,925,244		0
2018-07-03	2018-07-02	4	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock	C - Conversion	I			3,832,010			3,922,010
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series C Preferred Stock	C - Conversion	I			-2,525,253		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series B Preferred Stock	C - Conversion	I			-7,222,797		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Series A Preferred Stock	C - Conversion	I			-9,300,000		0
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	P - Purchase	I		13.0000	269,230	3,500		3,697,912
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			454,550			3,428,682
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			1,300,116			2,974,132
2018-07-03	2018-07-02	4	GLAXOSMITHKLINE PLC	TBIO	Common Stock	C - Conversion	I			1,674,016			1,674,016
2018-07-02	2018-07-02	4	Shire Human Genetic Therapies, Inc.	TBIO	Common Stock	J - Other	D			183,619			7,078,945
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13,790,650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13,790,650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13,790,650
2018-06-27		3	Shire plc	TBIO	Common Stock		D						13,790,650
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143,666
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143,666
2018-06-27		3	Burgess Paul D.	TBIO	Common Stock		D						143,666
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36,000
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36,000
2018-06-27		3	Heartlein Michael	TBIO	Common Stock		D						36,000
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643,650
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643,650
2018-06-27		3	LYNCH DANIEL	TBIO	Common Stock		D						643,650
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59,720
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59,720
2018-06-27		3	Hughes Owen	TBIO	Common Stock		D						59,720
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1,173,565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1,240,121
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1,173,565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1,240,121
2018-06-27		3	Renaud Ronald C JR By Ronald Renaud 2014 Irrevocable Family Trust	TBIO	Common Stock		I						1,173,565
2018-06-27		3	Renaud Ronald C JR	TBIO	Common Stock		D						1,240,121
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250,990
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250,990
2018-06-27		3	Fenton Brian	TBIO	Common Stock		D						250,990
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180,000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180,000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180,000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180,000
2018-06-27		3	Atlas Venture Associates VIII, Inc.	TBIO	Common Stock		D						180,000
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102,480
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102,480
2018-06-27		3	Cloghessy Paula	TBIO	Common Stock		D						102,480
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180,000
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180,000
2018-06-27		3	FORMELA JEAN FRANCOIS By Atlas Venture Fund VIII, L.P.	TBIO	Common Stock		I						180,000

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

TBIO / Telesis Bio, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5